Checkpoint Therapeutics Stock Ten Year Return

CKPT Stock  USD 4.39  0.11  2.57%   
Checkpoint Therapeutics fundamentals help investors to digest information that contributes to Checkpoint Therapeutics' financial success or failures. It also enables traders to predict the movement of Checkpoint Stock. The fundamental analysis module provides a way to measure Checkpoint Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Checkpoint Therapeutics stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Checkpoint Therapeutics Company Ten Year Return Analysis

Checkpoint Therapeutics' Ten Year Return shows the total annualized return generated from holding a fund for the last 10 years and represents fund's capital appreciation, including dividends losses and capital gains distributions. This return indicator is considered by many investors to be the ultimate measures of fund performance and can reflect the overall performance of the market or market segment it invests in.

Ten Year Return

 = 

(Mean of Monthly Returns - 1)

X

100%

More About Ten Year Return | All Equity Analysis

Checkpoint Ten Year Return Driver Correlations

Understanding the fundamental principles of building solid financial models for Checkpoint Therapeutics is extremely important. It helps to project a fair market value of Checkpoint Stock properly, considering its historical fundamentals such as Ten Year Return. Since Checkpoint Therapeutics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Checkpoint Therapeutics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Checkpoint Therapeutics' interrelated accounts and indicators.
0.860.73-0.120.440.220.310.631.00.630.75-0.170.260.270.470.470.6
0.860.460.34-0.010.19-0.210.290.860.290.51-0.460.43-0.180.750.750.62
0.730.46-0.570.410.040.540.850.730.850.580.34-0.240.56-0.15-0.150.14
-0.120.34-0.57-0.670.07-0.83-0.71-0.12-0.71-0.51-0.740.66-0.890.590.590.02
0.44-0.010.41-0.670.390.880.660.440.660.640.42-0.160.7-0.21-0.210.22
0.220.190.040.070.390.070.310.220.310.130.250.12-0.120.010.01-0.12
0.31-0.210.54-0.830.880.070.650.310.650.480.52-0.230.87-0.47-0.47-0.01
0.630.290.85-0.710.660.310.650.631.00.710.65-0.370.62-0.25-0.250.13
1.00.860.73-0.120.440.220.310.630.630.75-0.170.260.270.470.470.6
0.630.290.85-0.710.660.310.651.00.630.710.65-0.370.62-0.25-0.250.13
0.750.510.58-0.510.640.130.480.710.750.710.14-0.130.580.340.340.77
-0.17-0.460.34-0.740.420.250.520.65-0.170.650.14-0.630.49-0.76-0.76-0.46
0.260.43-0.240.66-0.160.12-0.23-0.370.26-0.37-0.13-0.63-0.310.610.610.16
0.27-0.180.56-0.890.7-0.120.870.620.270.620.580.49-0.31-0.35-0.350.16
0.470.75-0.150.59-0.210.01-0.47-0.250.47-0.250.34-0.760.61-0.351.00.77
0.470.75-0.150.59-0.210.01-0.47-0.250.47-0.250.34-0.760.61-0.351.00.77
0.60.620.140.020.22-0.12-0.010.130.60.130.77-0.460.160.160.770.77
Click cells to compare fundamentals
Although Ten Year Fund Return indicator can give a sense of overall fund long-term potential, it is recommended to compare funds performances against other similar funds or market benchmarks for the same 10-year interval.
Competition

Checkpoint Return On Tangible Assets

Return On Tangible Assets

(9.16)

At this time, Checkpoint Therapeutics' Return On Tangible Assets are comparatively stable compared to the past year.
Based on the latest financial disclosure, Checkpoint Therapeutics has a Ten Year Return of 0.0%. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).

Checkpoint Ten Year Return Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Checkpoint Therapeutics' direct or indirect competition against its Ten Year Return to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Checkpoint Therapeutics could also be used in its relative valuation, which is a method of valuing Checkpoint Therapeutics by comparing valuation metrics of similar companies.
Checkpoint Therapeutics is currently under evaluation in ten year return category among its peers.

Checkpoint Therapeutics ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Checkpoint Therapeutics' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Checkpoint Therapeutics' managers, analysts, and investors.
Environmental
Governance
Social

Checkpoint Fundamentals

About Checkpoint Therapeutics Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Checkpoint Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Checkpoint Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Checkpoint Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Checkpoint Stock Analysis

When running Checkpoint Therapeutics' price analysis, check to measure Checkpoint Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Checkpoint Therapeutics is operating at the current time. Most of Checkpoint Therapeutics' value examination focuses on studying past and present price action to predict the probability of Checkpoint Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Checkpoint Therapeutics' price. Additionally, you may evaluate how the addition of Checkpoint Therapeutics to your portfolios can decrease your overall portfolio volatility.